Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid
Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In...
Saved in:
Published in | Virology journal Vol. 12; no. 1; p. 95 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
22.06.2015
BioMed Central Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 1743-422X 1743-422X |
DOI | 10.1186/s12985-015-0321-5 |
Cover
Abstract | Background
The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus.
Results
A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10
5
–10
6
50 % tissue culture infective dose (TCID
50
)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin–Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method.
Conclusions
An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust “1 + 2” approach to generate influenza vaccine seed virus. |
---|---|
AbstractList | The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10.sup.5-10.sup.6 50 % tissue culture infective dose (TCID.sub.50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus. The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10(5)-10(6) 50% tissue culture infective dose (TCID50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus. The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus.BACKGROUNDThe current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus.A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10(5)-10(6) 50% tissue culture infective dose (TCID50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method.RESULTSA plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10(5)-10(6) 50% tissue culture infective dose (TCID50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method.An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus.CONCLUSIONSAn all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus. Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. Results A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10.sup.5-10.sup.6 50 % tissue culture infective dose (TCID.sub.50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. Conclusions An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus. Keywords: Influenza virus, Reverse genetics, Mouse RNA polymerase I promoter Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. Results A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10 5 –10 6 50 % tissue culture infective dose (TCID 50 )/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin–Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. Conclusions An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust “1 + 2” approach to generate influenza vaccine seed virus. BACKGROUND: The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. RESULTS: A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10⁵–10⁶ 50 % tissue culture infective dose (TCID₅₀)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin–Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. CONCLUSIONS: An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust “1 + 2” approach to generate influenza vaccine seed virus. |
ArticleNumber | 95 |
Audience | Academic |
Author | Curtiss, Roy Zhang, Xiangmin |
Author_xml | – sequence: 1 givenname: Xiangmin surname: Zhang fullname: Zhang, Xiangmin organization: Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy/Health Sciences, Wayne State University – sequence: 2 givenname: Roy surname: Curtiss fullname: Curtiss, Roy email: rcurtiss@ufl.edu organization: Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, School of Life Science, Arizona State University, Department of Infectious Diseases and Pathology, College of Veterinary Medicine, University of Florida |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26093583$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1rFDEYhQep2Hb1B3gjAW_qxdR8TDKZG2EpVReKQlXwLmQzyTYlk6zJzGr99b7rttIVqYSQr-e8SQ7nuDqIKdqqek7wKSFSvC6EdpLXmEBnlNT8UXVE2obVDaVfD-7ND6vjUq4xQKLtnlSHVOCOccmOKnXunDfexhGtbLRZjz5FlBzy0YXJxp8abXyeCvruxyuk0ZCmYtHlhzlap3AzgACWi7rPfmMj0iHUPtbwSrQOugy-f1o9djoU--x2nFVf3p5_PntfX3x8tzibX9RGNGKsqesJE3LpOi7o0rQGY0t7TESvHV9Szg3hWBreSswIwYY6wozAfGkEkw1v2ax6s6u7npaD7Q18KOug1tkPOt-opL3aP4n-Sq3SRjVNx1twY1ad3BbI6dtky6gGX4wNQUcLf1aMcCbalnf4vygRHSeSNrwB9OUOXelgFXia4HKzxdWcN4RTSaUE6vQfFLTeDt6Am87D_p7g1Z4AmNH-GFd6KkUtPl3usy_uO_PHkrsMANDuAJNTKdk6Zfz4OwfwCh8UwWqbNrVLm4K0qW3aFAcl-Ut5V_whDd1pCrBxZbO6TlOOkI0HRL8A6rrkJQ |
CitedBy_id | crossref_primary_10_1016_j_jviromet_2017_08_024 crossref_primary_10_3390_v9110332 crossref_primary_10_3390_v8060119 crossref_primary_10_4049_jimmunol_1600608 crossref_primary_10_1016_j_virol_2017_06_003 crossref_primary_10_1073_pnas_1700738114 crossref_primary_10_1016_j_vaccine_2016_07_010 crossref_primary_10_2217_fvl_2017_0046 crossref_primary_10_1021_acssynbio_3c00526 crossref_primary_10_1021_acssynbio_2c00358 crossref_primary_10_1146_annurev_virology_111821_120445 crossref_primary_10_1007_s11262_017_1457_8 crossref_primary_10_1016_j_nbt_2023_08_001 crossref_primary_10_1007_s12250_018_0066_6 crossref_primary_10_3390_ijms18010020 crossref_primary_10_1101_cshperspect_a038547 |
Cites_doi | 10.1099/vir.0.82452-0 10.1128/JVI.78.22.12683-12688.2004 10.1093/nar/27.19.3792 10.1007/BF00272905 10.1128/JVI.01468-14 10.1016/S1366-2120(07)70016-8 10.1128/JVI.73.11.9679-9682.1999 10.1099/0022-1317-81-12-2843 10.1016/j.vaccine.2006.03.012 10.1016/j.virol.2005.10.005 10.1128/JVI.01876-07 10.1093/emboj/16.6.1248 10.1073/pnas.1120265109 10.1016/j.virusres.2013.05.006 10.1086/507544 10.1002/btpr.2038 10.1128/JVI.70.6.4188-4192.1996 10.1128/JVI.01925-09 10.1016/S0042-6822(02)00035-1 10.1007/BF00353939 10.1073/pnas.100133697 10.1038/nature04378 10.1128/JVI.63.12.5142-5152.1989 10.1016/0959-437X(95)80035-2 10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G 10.3201/eid1201.051043 10.1016/j.vaccine.2009.02.064 10.1186/1743-422X-4-102 10.1016/j.vaccine.2004.08.054 10.1073/pnas.0505587102 10.1186/1471-2180-11-31 10.1128/JVI.01705-10 10.1073/pnas.96.16.9345 10.1016/0042-6822(88)90574-0 10.1016/S0264-410X(03)00071-9 10.1099/vir.0.051284-0 10.1007/BF00330768 10.1016/0092-8674(89)90766-6 10.1093/nar/21.16.3607 10.1128/JVI.79.21.13811-13816.2005 10.1128/JVI.00781-09 10.1128/JVI.02014-13 10.1007/s00253-011-3758-5 10.1371/journal.pone.0119041 10.1006/viro.1994.1365 10.1006/viro.1999.9892 10.1006/viro.2001.1008 |
ContentType | Journal Article |
Copyright | Zhang and Curtiss. 2015 COPYRIGHT 2015 BioMed Central Ltd. |
Copyright_xml | – notice: Zhang and Curtiss. 2015 – notice: COPYRIGHT 2015 BioMed Central Ltd. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 7X8 7S9 L.6 5PM |
DOI | 10.1186/s12985-015-0321-5 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic AGRICOLA |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1743-422X |
EndPage | 95 |
ExternalDocumentID | PMC4495709 A541528288 26093583 10_1186_s12985_015_0321_5 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI065779 – fundername: NIAID NIH HHS grantid: AI065779 |
GroupedDBID | --- 0R~ 123 29Q 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAHBH AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c646t-2fd1368bf9562bc7c00e2d016daf5b255c1508c57803110c2f13c605bc6384573 |
IEDL.DBID | M48 |
ISSN | 1743-422X |
IngestDate | Thu Aug 21 17:38:57 EDT 2025 Fri Sep 05 15:03:26 EDT 2025 Thu Sep 04 19:09:30 EDT 2025 Tue Jun 17 22:07:12 EDT 2025 Tue Jun 10 21:10:19 EDT 2025 Fri Jun 27 05:58:56 EDT 2025 Thu Apr 03 07:00:46 EDT 2025 Tue Jul 01 01:44:41 EDT 2025 Thu Apr 24 22:59:47 EDT 2025 Sat Sep 06 07:30:06 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Mouse RNA polymerase I promoter Influenza virus Reverse genetics |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c646t-2fd1368bf9562bc7c00e2d016daf5b255c1508c57803110c2f13c605bc6384573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12985-015-0321-5 |
PMID | 26093583 |
PQID | 1695182454 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4495709 proquest_miscellaneous_3153677590 proquest_miscellaneous_1695182454 gale_infotracmisc_A541528288 gale_infotracacademiconefile_A541528288 gale_incontextgauss_ISR_A541528288 pubmed_primary_26093583 crossref_citationtrail_10_1186_s12985_015_0321_5 crossref_primary_10_1186_s12985_015_0321_5 springer_journals_10_1186_s12985_015_0321_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-06-22 |
PublicationDateYYYYMMDD | 2015-06-22 |
PublicationDate_xml | – month: 06 year: 2015 text: 2015-06-22 day: 22 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Virology journal |
PublicationTitleAbbrev | Virol J |
PublicationTitleAlternate | Virol J |
PublicationYear | 2015 |
Publisher | BioMed Central BioMed Central Ltd |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd |
References | HF Maassab (321_CR22) 1999; 9 E Fodor (321_CR10) 1999; 73 P Suphaphiphat (321_CR45) 2010; 84 T Noda (321_CR1) 2006; 439 H Kallel (321_CR29) 2006; 24 C Sieben (321_CR37) 2012; 109 Z Wang (321_CR15) 2007; 4 M Baz (321_CR40) 2013; 178 KG Murti (321_CR2) 1988; 164 SL Londrigan (321_CR41) 2011; 85 G Neumann (321_CR9) 1999; 96 K Klumpp (321_CR3) 1997; 16 S Pleschka (321_CR8) 1996; 70 P Massin (321_CR16) 2005; 79 J Heix (321_CR13) 1995; 5 OW Merten (321_CR33) 1999; 98 EA Govorkova (321_CR32) 1999; 262 A Zobel (321_CR7) 1993; 21 P Reculard (321_CR30) 1996 W Luytjes (321_CR5) 1989; 59 JY Kim (321_CR31) 2012; 93 A Laban (321_CR46) 1981; 184 KL Nichol (321_CR35) 2006; 194 X Zhang (321_CR28) 2015; 10 N Lin (321_CR43) 2015; 31 L Monaco (321_CR38) 1996; 22 E Wit de (321_CR17) 2007; 88 X Zhang (321_CR19) 2009; 83 F Almazan (321_CR34) 2004; 78 WC Ng (321_CR42) 2014; 88 PD Minor (321_CR27) 2009; 27 E Hoffmann (321_CR11) 2000; 81 H Jin (321_CR26) 2003; 306 MS Song (321_CR44) 2013; 94 PS Hartman (321_CR48) 1991; 11 G Neumann (321_CR21) 2001; 287 JD Parvin (321_CR4) 1989; 63 E Hoffmann (321_CR12) 2000; 97 H Chen (321_CR20) 2014; 88 Z Chen (321_CR24) 2006; 345 G Neumann (321_CR6) 1994; 202 P Kreiss (321_CR36) 1999; 27 G Neumann (321_CR18) 2005; 102 P Palese (321_CR39) 2006; 12 X Zhang (321_CR50) 2011; 11 C Nicolson (321_CR23) 2005; 23 C Gerdil (321_CR25) 2003; 21 S Murakami (321_CR14) 2008; 82 M Matfield (321_CR47) 1985; 199 KN Rand (321_CR49) 1996; 1 11531402 - Virology. 2001 Sep 1;287(2):243-50 2598262 - Cell. 1989 Dec 22;59(6):1107-13 8664554 - Curr Opin Genet Dev. 1995 Oct;5(5):652-6 1809328 - Biotechniques. 1991 Dec;11(6):747-8 15507657 - J Virol. 2004 Nov;78(22):12683-8 22869709 - Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13626-31 17163383 - J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8 21191006 - J Virol. 2011 Mar;85(6):2990-3000 16600442 - Vaccine. 2006 May 29;24(22):4856-62 3369093 - Virology. 1988 Jun;164(2):562-6 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50 12620793 - Virology. 2003 Feb 1;306(1):18-24 24942589 - J Virol. 2014 Sep 1;88(17):10013-25 16494719 - Emerg Infect Dis. 2006 Jan;12(1):61-5 8648766 - J Virol. 1996 Jun;70(6):4188-92 10801978 - Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13 16227302 - J Virol. 2005 Nov;79(21):13811-6 20071567 - J Virol. 2010 Apr;84(7):3721-5 10489338 - Virology. 1999 Sep 15;262(1):31-8 24257596 - J Virol. 2014 Feb;88(3):1659-72 23726847 - Virus Res. 2013 Dec 5;178(1):78-98 16267134 - Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16825-9 18045936 - J Virol. 2008 Feb;82(3):1605-9 15780743 - Vaccine. 2005 Apr 22;23(22):2943-52 22159888 - Appl Microbiol Biotechnol. 2012 Feb;93(3):917-30 10481017 - Nucleic Acids Res. 1999 Oct 1;27(19):3792-8 11086114 - J Gen Virol. 2000 Dec;81(Pt 12):2843-7 23486669 - J Gen Virol. 2013 Jun;94(Pt 6):1230-5 10578119 - Rev Med Virol. 1999 Oct-Dec;9(4):237-44 7035834 - Mol Gen Genet. 1981;184(2):200-7 8009859 - Virology. 1994 Jul;202(1):477-9 16289204 - Virology. 2006 Feb 20;345(2):416-23 2993800 - Mol Gen Genet. 1985;199(3):518-23 25641927 - Biotechnol Prog. 2015 Mar-Apr;31(2):334-46 10516084 - J Virol. 1999 Nov;73(11):9679-82 19366582 - Vaccine. 2009 May 14;27(22):2907-13 16437116 - Nature. 2006 Jan 26;439(7075):490-2 22358930 - Cytotechnology. 1996 Jan;22(1-3):197-203 12686093 - Vaccine. 2003 May 1;21(16):1776-9 10494957 - Dev Biol Stand. 1999;98:23-37; discussion 73-4 8367275 - Nucleic Acids Res. 1993 Aug 11;21(16):3607-14 17956624 - Virol J. 2007;4:102 17374773 - J Gen Virol. 2007 Apr;88(Pt 4):1281-7 19587040 - J Virol. 2009 Sep;83(18):9296-303 2585601 - J Virol. 1989 Dec;63(12):5142-52 25742162 - PLoS One. 2015;10(3):e0119041 9135141 - EMBO J. 1997 Mar 17;16(6):1248-57 21303535 - BMC Microbiol. 2011;11:31 |
References_xml | – volume: 88 start-page: 1281 year: 2007 ident: 321_CR17 publication-title: J Gen Virol doi: 10.1099/vir.0.82452-0 – volume: 78 start-page: 12683 year: 2004 ident: 321_CR34 publication-title: J Virol doi: 10.1128/JVI.78.22.12683-12688.2004 – volume: 27 start-page: 3792 year: 1999 ident: 321_CR36 publication-title: Nucleic Acids Res doi: 10.1093/nar/27.19.3792 – volume: 184 start-page: 200 year: 1981 ident: 321_CR46 publication-title: Mol Gen Genet doi: 10.1007/BF00272905 – volume: 88 start-page: 10013 year: 2014 ident: 321_CR20 publication-title: J Virol doi: 10.1128/JVI.01468-14 – volume: 1 start-page: 23 year: 1996 ident: 321_CR49 publication-title: Tech Tips Online doi: 10.1016/S1366-2120(07)70016-8 – volume: 73 start-page: 9679 year: 1999 ident: 321_CR10 publication-title: J Virol doi: 10.1128/JVI.73.11.9679-9682.1999 – volume: 81 start-page: 2843 year: 2000 ident: 321_CR11 publication-title: J Gen Virol doi: 10.1099/0022-1317-81-12-2843 – volume: 24 start-page: 4856 year: 2006 ident: 321_CR29 publication-title: Vaccine doi: 10.1016/j.vaccine.2006.03.012 – volume: 345 start-page: 416 year: 2006 ident: 321_CR24 publication-title: Virology doi: 10.1016/j.virol.2005.10.005 – volume: 82 start-page: 1605 year: 2008 ident: 321_CR14 publication-title: J Virol doi: 10.1128/JVI.01876-07 – volume: 16 start-page: 1248 year: 1997 ident: 321_CR3 publication-title: EMBO J doi: 10.1093/emboj/16.6.1248 – volume: 109 start-page: 13626 year: 2012 ident: 321_CR37 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1120265109 – volume: 178 start-page: 78 year: 2013 ident: 321_CR40 publication-title: Virus Res doi: 10.1016/j.virusres.2013.05.006 – volume: 194 start-page: S111 issue: Suppl 2 year: 2006 ident: 321_CR35 publication-title: J Infect Dis doi: 10.1086/507544 – volume: 31 start-page: 334 year: 2015 ident: 321_CR43 publication-title: Biotechnol Prog doi: 10.1002/btpr.2038 – volume: 70 start-page: 4188 year: 1996 ident: 321_CR8 publication-title: J Virol doi: 10.1128/JVI.70.6.4188-4192.1996 – volume: 84 start-page: 3721 year: 2010 ident: 321_CR45 publication-title: J Virol doi: 10.1128/JVI.01925-09 – volume: 11 start-page: 747 year: 1991 ident: 321_CR48 publication-title: Biotechniques – volume: 306 start-page: 18 year: 2003 ident: 321_CR26 publication-title: Virology doi: 10.1016/S0042-6822(02)00035-1 – volume: 22 start-page: 197 year: 1996 ident: 321_CR38 publication-title: Cytotechnology doi: 10.1007/BF00353939 – volume: 97 start-page: 6108 year: 2000 ident: 321_CR12 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.100133697 – start-page: 314 volume-title: Laboratory techniques in rabies year: 1996 ident: 321_CR30 – volume: 439 start-page: 490 year: 2006 ident: 321_CR1 publication-title: Nature doi: 10.1038/nature04378 – volume: 63 start-page: 5142 year: 1989 ident: 321_CR4 publication-title: J Virol doi: 10.1128/JVI.63.12.5142-5152.1989 – volume: 5 start-page: 652 year: 1995 ident: 321_CR13 publication-title: Curr Opin Genet Dev doi: 10.1016/0959-437X(95)80035-2 – volume: 9 start-page: 237 year: 1999 ident: 321_CR22 publication-title: Rev Med Virol doi: 10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G – volume: 12 start-page: 61 year: 2006 ident: 321_CR39 publication-title: Emerg Infect Dis doi: 10.3201/eid1201.051043 – volume: 27 start-page: 2907 year: 2009 ident: 321_CR27 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.02.064 – volume: 4 start-page: 102 year: 2007 ident: 321_CR15 publication-title: Virol J doi: 10.1186/1743-422X-4-102 – volume: 23 start-page: 2943 year: 2005 ident: 321_CR23 publication-title: Vaccine doi: 10.1016/j.vaccine.2004.08.054 – volume: 102 start-page: 16825 year: 2005 ident: 321_CR18 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0505587102 – volume: 11 start-page: 31 year: 2011 ident: 321_CR50 publication-title: BMC Microbiol doi: 10.1186/1471-2180-11-31 – volume: 85 start-page: 2990 year: 2011 ident: 321_CR41 publication-title: J Virol doi: 10.1128/JVI.01705-10 – volume: 98 start-page: 23 year: 1999 ident: 321_CR33 publication-title: Dev Biol Stand – volume: 96 start-page: 9345 year: 1999 ident: 321_CR9 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.96.16.9345 – volume: 164 start-page: 562 year: 1988 ident: 321_CR2 publication-title: Virology doi: 10.1016/0042-6822(88)90574-0 – volume: 21 start-page: 1776 year: 2003 ident: 321_CR25 publication-title: Vaccine doi: 10.1016/S0264-410X(03)00071-9 – volume: 94 start-page: 1230 year: 2013 ident: 321_CR44 publication-title: J Gen Virol doi: 10.1099/vir.0.051284-0 – volume: 199 start-page: 518 year: 1985 ident: 321_CR47 publication-title: Mol Gen Genet doi: 10.1007/BF00330768 – volume: 59 start-page: 1107 year: 1989 ident: 321_CR5 publication-title: Cell doi: 10.1016/0092-8674(89)90766-6 – volume: 21 start-page: 3607 year: 1993 ident: 321_CR7 publication-title: Nucleic Acids Res doi: 10.1093/nar/21.16.3607 – volume: 79 start-page: 13811 year: 2005 ident: 321_CR16 publication-title: J Virol doi: 10.1128/JVI.79.21.13811-13816.2005 – volume: 83 start-page: 9296 year: 2009 ident: 321_CR19 publication-title: J Virol doi: 10.1128/JVI.00781-09 – volume: 88 start-page: 1659 year: 2014 ident: 321_CR42 publication-title: J Virol doi: 10.1128/JVI.02014-13 – volume: 93 start-page: 917 year: 2012 ident: 321_CR31 publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-011-3758-5 – volume: 10 start-page: e0119041 year: 2015 ident: 321_CR28 publication-title: PLoS One doi: 10.1371/journal.pone.0119041 – volume: 202 start-page: 477 year: 1994 ident: 321_CR6 publication-title: Virology doi: 10.1006/viro.1994.1365 – volume: 262 start-page: 31 year: 1999 ident: 321_CR32 publication-title: Virology doi: 10.1006/viro.1999.9892 – volume: 287 start-page: 243 year: 2001 ident: 321_CR21 publication-title: Virology doi: 10.1006/viro.2001.1008 – reference: 16600442 - Vaccine. 2006 May 29;24(22):4856-62 – reference: 25742162 - PLoS One. 2015;10(3):e0119041 – reference: 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50 – reference: 25641927 - Biotechnol Prog. 2015 Mar-Apr;31(2):334-46 – reference: 2993800 - Mol Gen Genet. 1985;199(3):518-23 – reference: 21303535 - BMC Microbiol. 2011;11:31 – reference: 9135141 - EMBO J. 1997 Mar 17;16(6):1248-57 – reference: 10578119 - Rev Med Virol. 1999 Oct-Dec;9(4):237-44 – reference: 17956624 - Virol J. 2007;4:102 – reference: 10494957 - Dev Biol Stand. 1999;98:23-37; discussion 73-4 – reference: 2598262 - Cell. 1989 Dec 22;59(6):1107-13 – reference: 16267134 - Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16825-9 – reference: 8648766 - J Virol. 1996 Jun;70(6):4188-92 – reference: 19366582 - Vaccine. 2009 May 14;27(22):2907-13 – reference: 24257596 - J Virol. 2014 Feb;88(3):1659-72 – reference: 16494719 - Emerg Infect Dis. 2006 Jan;12(1):61-5 – reference: 11086114 - J Gen Virol. 2000 Dec;81(Pt 12):2843-7 – reference: 19587040 - J Virol. 2009 Sep;83(18):9296-303 – reference: 11531402 - Virology. 2001 Sep 1;287(2):243-50 – reference: 18045936 - J Virol. 2008 Feb;82(3):1605-9 – reference: 23486669 - J Gen Virol. 2013 Jun;94(Pt 6):1230-5 – reference: 10801978 - Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13 – reference: 16289204 - Virology. 2006 Feb 20;345(2):416-23 – reference: 1809328 - Biotechniques. 1991 Dec;11(6):747-8 – reference: 2585601 - J Virol. 1989 Dec;63(12):5142-52 – reference: 10489338 - Virology. 1999 Sep 15;262(1):31-8 – reference: 17374773 - J Gen Virol. 2007 Apr;88(Pt 4):1281-7 – reference: 20071567 - J Virol. 2010 Apr;84(7):3721-5 – reference: 7035834 - Mol Gen Genet. 1981;184(2):200-7 – reference: 3369093 - Virology. 1988 Jun;164(2):562-6 – reference: 22869709 - Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13626-31 – reference: 12620793 - Virology. 2003 Feb 1;306(1):18-24 – reference: 8664554 - Curr Opin Genet Dev. 1995 Oct;5(5):652-6 – reference: 22159888 - Appl Microbiol Biotechnol. 2012 Feb;93(3):917-30 – reference: 15507657 - J Virol. 2004 Nov;78(22):12683-8 – reference: 8009859 - Virology. 1994 Jul;202(1):477-9 – reference: 12686093 - Vaccine. 2003 May 1;21(16):1776-9 – reference: 10516084 - J Virol. 1999 Nov;73(11):9679-82 – reference: 10481017 - Nucleic Acids Res. 1999 Oct 1;27(19):3792-8 – reference: 17163383 - J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8 – reference: 24942589 - J Virol. 2014 Sep 1;88(17):10013-25 – reference: 16227302 - J Virol. 2005 Nov;79(21):13811-6 – reference: 16437116 - Nature. 2006 Jan 26;439(7075):490-2 – reference: 15780743 - Vaccine. 2005 Apr 22;23(22):2943-52 – reference: 23726847 - Virus Res. 2013 Dec 5;178(1):78-98 – reference: 8367275 - Nucleic Acids Res. 1993 Aug 11;21(16):3607-14 – reference: 22358930 - Cytotechnology. 1996 Jan;22(1-3):197-203 – reference: 21191006 - J Virol. 2011 Mar;85(6):2990-3000 |
SSID | ssj0032679 |
Score | 2.1728234 |
Snippet | Background
The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to... The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be... Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to... BACKGROUND: The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 95 |
SubjectTerms | Animals Antigens, Viral - biosynthesis Antigens, Viral - genetics Biomedical and Life Sciences Biomedicine CHO Cells cost effectiveness Cricetulus Cricetulus griseus DNA-directed RNA polymerase Dogs Epidemics Genetic aspects hamsters Influenza Influenza A virus Influenza vaccines Influenza Vaccines - genetics Influenza Vaccines - immunology Influenza viruses kidneys Madin Darby Canine Kidney Cells Mice Orthomyxoviridae - genetics pandemic Physiological aspects Plasmids Proteins reverse genetics Reverse Genetics - methods RNA RNA Polymerase I - metabolism RNA, Viral - biosynthesis RNA, Viral - genetics tissue culture Vaccines, Attenuated - genetics Vaccines, Attenuated - immunology Virology viruses |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB-0ovgiWrVGW1lFEJTFJPuRvcfjaGmF9qFa6Nuy2U1q4Jo7LndC_eudSXJHc1ihD3kIO0nIzvfO7m8APgVqayQSwYVUgUshUee0y7kOLk-CScrC0Nnh0zN9fCG_X6rLHiyazsLcrt8nRn9r0B8Z2l6Gl0gTrh7CI4V2l4R5oidro4tBSDbqi5b_fGzgdraN7y3vs70zcqs82nqdo-fwrA8X2bjj7wt4UNS78LhrIHmzC09O-9L4S7CHLRgEvpFdtVDSNONsVrKqa0Pyx7Hf1WLVMFp5ZY5Ryl-w87Mxm8-mN7Q0hbcnPCzI_DE3nfKq5rO6YHOMr6-r8Aoujg5_To553z2Bey31kqdlSIQ2eYkZUJr7zMdxkQaM8IIrVY6ZhCcoeI8ai3qdxD4tE-Exuck9qqRUmXgNOzV-5g0wr_JM5pkvQhGkd2rkAiZCsTcYv5WxdhHE68m1vocWpw4XU9umGEbbjh8W-WGJH1ZF8GXzyLzD1fgf8UfimCW8ipo2xFy5VdPYkx_ndqwoAsG00UTwuScqZ_hx7_rzBfgLBHE1oNwfUKJC-cHwh7VgWBqiXWh1gUyxicZ41KRSybtpBLoQnWVqFEew1wnT5gcxd6Sys4ggG4jZhoCwvocjdfWrxfyWmMhm8SiCr2uBtL2xae6et7f3on4HT9NWYTRP033YWS5WxQFGXMv8fatrfwGktyGV priority: 102 providerName: Springer Nature |
Title | Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid |
URI | https://link.springer.com/article/10.1186/s12985-015-0321-5 https://www.ncbi.nlm.nih.gov/pubmed/26093583 https://www.proquest.com/docview/1695182454 https://www.proquest.com/docview/3153677590 https://pubmed.ncbi.nlm.nih.gov/PMC4495709 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ri9NAEF_ugeIX0fMVPcsqgqBE89hH-kGklh53hSvSs9Bvy2Y3OQu9tNeHWP96ZzZJMeXqhxLanTTJzszOzM7kN4S8s9jWKA5jP2bc-ixmoHNCp76wOg1tEuZZgu8OXw7E-Yj1x3x8QOr2VtUELu8M7bCf1Ggx_fT7dvMVFP6LU_hEfF6CzUqwBA0-cRT6_JAcu3QRVvKxbVIBHBXZrhKbd56GwMDCJQbjhpXaXav_MVa7hZQ72VRnpM4ekYeVd0k7pTg8JgdZcULulf0mNyfk_mWVSX9CVM9hR8A_0muHPI0MorOcTsquJX80_TVZrJcUN2qpprhDkNHhoEPns-kGd7Lg64VvF7haUj2d-pPCnxUZnYM7fjOxT8norPeje-5XzRZ8I5hY-VFuw1gkaQ4BU5QaaYIgiyw4hFbnPIXAwyByvAEFh2UgDEyUh7GBWCg1oMGMy_gZOSrgMi8INTyVLJUms5llRvO2thA3BSYBdy8PhPZIUE-uMhUSOTbEmCoXkSRClaxRwBqFrFHcIx-2p8xLGI7_Eb9FjimEtyiwfuZar5dLdXE1VB2ODgtEmYlH3ldE-QwubnT1OgI8AiJiNShPG5Sgf6Yx_KYWDIVDWLRWZMAUFQpwX5OIcbafJgaLI6Tk7cAjz0th2j5gLYwekQ0x2xIgNHhzpJj8dBDhDOJeGbQ98rEWSFWr1v55e7n3Dl6RB5HTE-FH0Sk5Wi3W2WtwxlZpixzKsWyR406nf9WH47fe4PsQfu2KbsttcLScEv4FNfEx0g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwED7BEIwXBANGYIBBSEggiyT-kfSxqja1sPZhbNLeLMdORqWSVk2LNP567pK0WiqGxEMeIl8Sxefz3eezvwP44KmskYgEF1J5LoVEm9M249rbLPJpVOQpnR0eT_TwQn69VJctWTSdhbmZv49S_aVCf5TS9jK8RBxxdRfuUeKSaPIHerCZdDEISXpt0vKvj3Xczu7ke8P77O6M3EmP1l7n5DE8asNF1m_0-wTu5OUB3G8KSF4fwINxmxp_Cua4JoPAN7KrmkqaepzNCzZtypD8tuzXdLmuGK28MssI8ufsbNJni_nsmpam8HbE_ZKmP2ZnMz4t-bzM2QLj659T_wwuTo7PB0PeVk_gTku94nHhI6HTrEAEFGcucWGYxx4jPG8LlSGScEQF79Bi0a6j0MVFJByCm8yhSUqViOewV-JnXgBzKktklrjc5146q3rWIxAKXYrxWxFqG0C46VzjWmpxqnAxMzXESLVp9GFQH4b0YVQAn7aPLBpejX8JvyeNGeKrKGlDzJVdV5UZfT8zfUURCMLGNICPrVAxx487254vwF8giquO5FFHEg3KdZrfbQaGoSbahVbmqBQTaYxH01gqebuMQBeik0T1wgAOm8G0_UHEjpR2FgEknWG2FSCu725LOf1Rc35LBLJJ2Avg82ZAmnayqW7vt5f_Jf0W9ofn41NzOpp8ewUP49p4NI_jI9hbLdf5a4y-Vtmb2u7-AGuQJIQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgExMvCMZXxgCDkJBA1vJhO85jBKvWwiq0MWlvlmMnI1KXVk2LNP567vJRkYoh8dCHyJdGyfl89_Odf0fIO4dtjaIgYhEXjvGIg81JkzHpTBY4FRS5wrPDp1N5csEnl-Ky63Na99XufUqyPdOALE3V6mjhitbElTyqwUspLDqDXxQGTNwlu0okCaCv3TSdnE_6xRiCkzjpkpl_vXHgjrYX5T-80nbF5FbatPFGo4fkQRdG0rTV-yNyJ6_2yb22seTNPtk77VLmj4k-bkgi4B_pVUMxjZqg84KWbXuSX4b-LJfrmuKOLDUUtwJyejZN6WI-u8EtK7gcM7fEZZGa2YyVFZtXOV1A3H1duifkYnT8_dMJ67oqMCu5XLGwcEEkVVYAMgozG1vfz0MHkZ8zhcgAYVikiLdgyWDvgW_DIogsgJ7MgqlyEUdPyU4Fj3lOqBVZzLPY5i533BqRGAcAybcK4rrCl8Yjfv9xte0ox7HzxUw30ENJ3epDgz406kMLj3zY3LJo-Tb-JfwWNaaRx6LCQpkrs65rPT4_06nAyATgpPLI-06omMPDrenOHcArIPXVQPJwIAmGZgfDb_qJoXEIq9OqHJSiAwlxqgq54LfLROBaZByLxPfIs3YybV4QMCWmoyOPxINpthFADvDhSFX-aLjAOQDc2E888rGfkLpbhOrbv9vBf0m_JnvfPo_01_H0ywtyP2xsR7IwPCQ7q-U6fwlB2Sp71Rneb9KMLkI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficient+generation+of+influenza+virus+with+a+mouse+RNA+polymerase+I-driven+all-in-one+plasmid&rft.jtitle=Virology+journal&rft.au=Zhang%2C+Xiangmin&rft.au=Curtiss%2C+3rd%2C+Roy&rft.date=2015-06-22&rft.eissn=1743-422X&rft.volume=12&rft.spage=95&rft_id=info:doi/10.1186%2Fs12985-015-0321-5&rft_id=info%3Apmid%2F26093583&rft.externalDocID=26093583 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon |